ID   TENR_RAT                Reviewed;        1356 AA.
AC   Q05546;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-JUL-2015, entry version 121.
DE   RecName: Full=Tenascin-R;
DE            Short=TN-R;
DE   AltName: Full=Janusin;
DE   AltName: Full=Neural recognition molecule J1-160/180;
DE   AltName: Full=Restrictin;
DE   Flags: Precursor;
GN   Name=Tnr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), DEVELOPMENTAL STAGE,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=7679676; DOI=10.1083/jcb.120.5.1237;
RA   Fuss B., Wintergerst E.-S., Bartsch U., Schachner M.;
RT   "Molecular characterization and in situ mRNA localization of the
RT   neural recognition molecule J1-160/180: a modular structure similar to
RT   tenascin.";
RL   J. Cell Biol. 120:1237-1249(1993).
RN   [2]
RP   INTERACTION WITH CNTN1.
RX   PubMed=9081628; DOI=10.1111/j.1460-9568.1996.tb01262.x;
RA   Xiao Z.-C., Taylor J., Montag D., Rougon G., Schachner M.;
RT   "Distinct effects of recombinant tenascin-R domains in neuronal cell
RT   functions and identification of the domain interacting with the
RT   neuronal recognition molecule F3/11.";
RL   Eur. J. Neurosci. 8:766-782(1996).
RN   [3]
RP   INTERACTION WITH BCAN.
RX   PubMed=9294172; DOI=10.1073/pnas.94.19.10116;
RA   Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D.,
RA   Schachner M., Ruoslahti E., Yamaguchi Y.;
RT   "The C-type lectin domains of lecticans, a family of aggregating
RT   chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein
RT   interactions independent of carbohydrate moiety.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:10116-10121(1997).
RN   [4]
RP   INTERACTION WITH SCN2B, AND FUNCTION.
RX   PubMed=9861042; DOI=10.1073/pnas.95.26.15753;
RA   Srinivasan J., Schachner M., Catterall W.A.;
RT   "Interaction of voltage-gated sodium channels with the extracellular
RT   matrix molecules tenascin-C and tenascin-R.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15753-15757(1998).
RN   [5]
RP   INTERACTION WITH PTPRZ1 AND CSPG3.
RX   PubMed=9507007; DOI=10.1074/jbc.273.12.6998;
RA   Milev P., Chiba A., Haring M., Rauvala H., Schachner M., Ranscht B.,
RA   Margolis R.K., Margolis R.U.;
RT   "High affinity binding and overlapping localization of neurocan and
RT   phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R,
RT   amphoterin, and the heparin-binding growth-associated molecule.";
RL   J. Biol. Chem. 273:6998-7005(1998).
RN   [6]
RP   GLYCOSYLATION, AND FUNCTION.
RX   PubMed=10723065;
RX   DOI=10.1002/(SICI)1097-4547(20000401)60:1<21::AID-JNR3>3.0.CO;2-H;
RA   Probstmeier R., Stichel C.C., Muller H.W., Asou H., Pesheva P.;
RT   "Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R
RT   are involved in neural cell recognition. Functional implications
RT   during CNS development and regeneration.";
RL   J. Neurosci. Res. 60:21-36(2000).
RN   [7]
RP   GLYCOSYLATION.
RX   PubMed=12393878; DOI=10.1074/jbc.M209876200;
RA   Woodworth A., Fiete D., Baenziger J.U.;
RT   "Spatial and temporal regulation of tenascin-R glycosylation in the
RT   cerebellum.";
RL   J. Biol. Chem. 277:50941-50947(2002).
RN   [8]
RP   GLYCOSYLATION, DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=14681222; DOI=10.1074/jbc.M312466200;
RA   Woodworth A., Pesheva P., Fiete D., Baenziger J.U.;
RT   "Neuronal-specific synthesis and glycosylation of tenascin-R.";
RL   J. Biol. Chem. 279:10413-10421(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 489-771, AND INTERACTION WITH
RP   ACAN.
RX   PubMed=15296743; DOI=10.1016/j.str.2004.05.021;
RA   Lundell A., Olin A.I., Morgelin M., al-Karadaghi S., Aspberg A.,
RA   Logan D.T.;
RT   "Structural basis for interactions between tenascins and lectican C-
RT   type lectin domains: evidence for a crosslinking role for tenascins.";
RL   Structure 12:1495-1506(2004).
CC   -!- FUNCTION: Neural extracellular matrix (ECM) protein involved in
CC       interactions with different cells and matrix components. Theses
CC       interactions can influence cellular behavior by either evoking a
CC       stable adhesion and differentiation, or repulsion and inhibition
CC       of neurite growth. Binding to cell surface gangliosides inhibits
CC       RGD-dependent integrin-mediated cell adhesion and results in an
CC       inhibition of PTK2/FAK1 (FAK) phosphorylation and cell detachment.
CC       Binding to membrane surface sulfatides results in a
CC       oligodendrocyte adhesion and differentiation. Interaction with
CC       CNTN1 induces a repulsion of neurons and an inhibition of neurite
CC       outgrowth. Interacts with SCN2B may play a crucial role in
CC       clustering and regulation of activity of sodium channels at nodes
CC       of Ranvier. TNR-linked chondroitin sulfate glycosaminoglycans are
CC       involved in the interaction with FN1 and mediates inhibition of
CC       cell adhesion and neurite outgrowth. The highly regulated addition
CC       of sulfated carbohydrate structure may modulate the adhesive
CC       properties of TNR over the course of development and during
CC       synapse maintenance (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. Interacts with TNC and FN1 (By
CC       similarity). Interacts with BCAN and ACAN in a calcium -dependent
CC       manner. Interacts with CNTN1, SCN2B, PTPRZ1, and CSPG3.
CC       {ECO:0000250, ECO:0000269|PubMed:15296743,
CC       ECO:0000269|PubMed:9081628, ECO:0000269|PubMed:9294172,
CC       ECO:0000269|PubMed:9507007, ECO:0000269|PubMed:9861042}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=TN-R 180, 180 kDa form;
CC         IsoId=Q05546-1; Sequence=Displayed;
CC       Name=2; Synonyms=TN-R 160, 160 kDa form;
CC         IsoId=Q05546-2; Sequence=VSP_012995;
CC   -!- TISSUE SPECIFICITY: Brain-specific. Expressed in oligodendrocytes
CC       and small subsets of neurons (mainly interneurons and motoneurons)
CC       of the cerebellum, hippocampus and olfactory bulb.
CC       {ECO:0000269|PubMed:7679676}.
CC   -!- DEVELOPMENTAL STAGE: Expression in oligodendrocytes is highest
CC       between the second and third postnatal week and low in the adult.
CC       In contrast the expression in neurons increases from birth to
CC       third postnatal week and is continuous from late development to
CC       adulthood. Isoform 1 is the dominant form early in development.
CC       Isoform 2 is more prominent later in development and in adulthood.
CC       {ECO:0000269|PubMed:14681222, ECO:0000269|PubMed:7679676}.
CC   -!- DOMAIN: The EGF-like domains mediate interaction with CNTN1. The
CC       fibronectin type-III domains 3-5 mediate interaction with BCAN.
CC       The fibronectin type-III domains 1-2 and 7-9 mediate interaction
CC       with SCN2B.
CC   -!- PTM: Contains N-linked oligosaccharides, O-linked sialylated
CC       structures (By similarity). Contains O-linked chondroitin sulfate
CC       glycosaminoglycans. Contains N-linked oligosaccharides with a
CC       sulfated carbohydrate structure type GalNAc-4-SO4 or HNK-1 (SO4-3-
CC       GlcUABeta1,3GalBeta1,4GlcNAc). The levels of HNK-1 rise and fall
CC       in parallel to those of TNR during postnatal development of the
CC       cerebellum. In contrast, levels of GalNAc-4-SO4 are regulated
CC       independently from those of TNR, rising late in cerebellar
CC       development and continuing into adulthood. Early in postnatal
CC       development, GalNAc-4-SO4 is found predominantly on isoform 1,
CC       whereas in the adult it is predominantly on isoform 2.
CC       {ECO:0000250, ECO:0000269|PubMed:10723065,
CC       ECO:0000269|PubMed:12393878, ECO:0000269|PubMed:14681222}.
CC   -!- SIMILARITY: Belongs to the tenascin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 5 EGF-like domains. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 fibrinogen C-terminal domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00739}.
CC   -!- SIMILARITY: Contains 9 fibronectin type-III domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00316}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z18630; CAA79229.1; -; mRNA.
DR   PIR; A45445; A45445.
DR   RefSeq; NP_037177.1; NM_013045.1. [Q05546-1]
DR   UniGene; Rn.11028; -.
DR   UniGene; Rn.131578; -.
DR   PDB; 1TDQ; X-ray; 2.60 A; A=502-771.
DR   PDBsum; 1TDQ; -.
DR   ProteinModelPortal; Q05546; -.
DR   SMR; Q05546; 502-770.
DR   BioGrid; 247598; 1.
DR   IntAct; Q05546; 1.
DR   PhosphoSite; Q05546; -.
DR   PaxDb; Q05546; -.
DR   PRIDE; Q05546; -.
DR   GeneID; 25567; -.
DR   KEGG; rno:25567; -.
DR   CTD; 7143; -.
DR   RGD; 3886; Tnr.
DR   eggNOG; NOG311251; -.
DR   HOGENOM; HOG000234355; -.
DR   HOVERGEN; HBG008949; -.
DR   InParanoid; Q05546; -.
DR   KO; K06252; -.
DR   PhylomeDB; Q05546; -.
DR   EvolutionaryTrace; Q05546; -.
DR   NextBio; 607175; -.
DR   PRO; PR:Q05546; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; Q05546; RN.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IDA:RGD.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:RGD.
DR   GO; GO:0007399; P:nervous system development; TAS:RGD.
DR   Gene3D; 2.60.40.10; -; 9.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR000742; EG-like_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 9.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 9.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Coiled coil;
KW   Complete proteome; Disulfide bond; EGF-like domain;
KW   Extracellular matrix; Glycoprotein; Proteoglycan; Reference proteome;
KW   Repeat; Secreted; Sialic acid; Signal.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32   1356       Tenascin-R.
FT                                /FTId=PRO_0000007749.
FT   DOMAIN      188    199       EGF-like 1.
FT   DOMAIN      204    230       EGF-like 2.
FT   DOMAIN      235    261       EGF-like 3.
FT   DOMAIN      281    292       EGF-like 4.
FT   DOMAIN      293    324       EGF-like 5.
FT   DOMAIN      328    419       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      420    504       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      505    596       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      597    686       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      687    776       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      777    864       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      865    953       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      954   1040       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1041   1129       Fibronectin type-III 9.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1127   1342       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   COILED      127    157       {ECO:0000255}.
FT   COMPBIAS    155    314       Cys-rich.
FT   CARBOHYD     55     55       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    180    180       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    580    580       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    790    790       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    868    868       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    873    873       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1034   1034       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1044   1044       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1259   1259       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    297    307       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    314    323       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   VAR_SEQ     772    861       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7679676}.
FT                                /FTId=VSP_012995.
FT   STRAND      507    514       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      519    524       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      531    543       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      547    551       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      556    560       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      568    577       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      585    590       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      597    604       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      609    614       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      621    629       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      636    641       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      644    652       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      660    669       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      677    682       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      689    696       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      701    706       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      713    720       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      722    724       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      727    734       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      736    740       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      749    757       {ECO:0000244|PDB:1TDQ}.
FT   STRAND      765    769       {ECO:0000244|PDB:1TDQ}.
SQ   SEQUENCE   1356 AA;  149371 MW;  9BFE2BF7AD4CA781 CRC64;
     MGIEGETVVL KNMLIGVNLI LLGSMLKPSE CRLEVTTERV QRQTVEEEGG ASSYNTSSKE
     QPMVFNHVYN INVPLESLCS SGLEASAEQD VSAEDDTLAE YTGQTSDHES QVTFTHKINL
     PKKACPCASS AQVLQELLSR IEMLEREVSV LRDQCNTNCC QESAATGQLD YVPHCSGHGN
     FSFESCGCIC NEGWFGKNCS EPYCPLGCSS RGVCVDGQCI CDSEYSGDDC SELRCPTDCS
     SRGLCVDGEC VCEEPYTGED CRELRCPGDC SGKGQCANGT CLCQEGYAGE DCSQRRCLNA
     CSGRGHCQEG LCICEEGYQG PDCSAVTPPE DLRVAGISDR SIELEWDGPM AVTEYVISYQ
     PSLGGLQLQQ RVPGDWSGVT ITELEPGLTY NISVYAVISN ILSLPITAKV ATHLSTPQGL
     QFKTITETTV EVQWEPFSFS FDGWEISFTP KNNEGGVIAQ LPSDVTSFNQ TGLKPGEEYI
     VNVVALKEQA RGPPTSASVS TVIDGPTQIL VRDVSDTVAF VEWTPPRAKV DFILLKYGLV
     GGEGGKTTFR LQPPLSQYSV QALRPGSRYE VSISAVRGTN ESDASSTQFT TEIDAPKNLR
     VGSRTATSLD LEWDNSEAEA QEYKVVYSTL AGEQYHEVLV PKGIGPTTKT TLTDLVPGTE
     YGVGISAVMN SKQSIPATMN ARTELDSPRD LMVTASSETS ISLIWTKASG PIDHYRITFT
     PSSGISSEVT VPRDRTSYTL TDLEPGAEYI ISITAERGRQ QSLESTVDAF TGFRPISHLH
     FSHVTSSSVN ITWSDPSPPA DRLILNYSPR DEEEEMMEVL LDATKRHAVL MGLQPATEYI
     VNLVAVHGTV TSEPIVGSIT TGIDPPKNIT ISNVTKDSLT VSWSPPVAPF DYYEYPIDHP
     SGRLDSSVVP NTVTEFTITR LYPASQYEIS LNSVRGREES ERICTLVHTA MDSPMDLIAT
     NITPTEALLQ WKAPMGEVEN YVIVLTHFAM AGETILVDGV SEEFQLVDLL PRTHYTVTMY
     ATSGPLVSGT IATNFSTLLD PPANLTASEV TRQSALISWQ PPRAAIENYV LTYKSTDGSR
     KELIVDAEDT WIRLEGLSEN TDYTVLLQAA QEATRSSLTS TIFTTGGRVF SHPQDCAQHL
     MNGDTLSGVY TIFLNGELSH KLQVYCDMTT DGGGWIVFQR RQNGQTDFFR KWADYRVGFG
     NLEDEFWLGL DNYHRITAQG RYELRVDMRD GQEAVFAYYD KFAVEDSRSL YKLRIGGYNG
     TAGDSLSYHQ GRPFSTEDRD NDVAVTNCAM SYKGAWWYKN CHRTNLNGKY GESRHSQGIN
     WYHWKGHEFS IPFVEMKMRP YIHRLTAGRK RRALKF
//
